Homogeneous BTK Occupancy Assay for Pharmacodynamic Assessment of Tirabrutinib (GS-4059/ONO-4059) Target Engagement

Bruton’s tyrosine kinase (BTK) is a clinically validated target for B-cell leukemias and lymphomas with FDA-approved small-molecule inhibitors ibrutinib and acalabrutinib. Tirabrutinib (GS-4059/ONO-4059, Gilead Sciences, Inc., Foster City, CA) is a second-generation, potent, selective, irreversible...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:SLAS Discov
Main Authors: Yu, Helen, Truong, Hoa, Mitchell, Scott A., Liclican, Albert, Gosink, John J., Li, Wanying, Lin, Julie, Feng, Joy Y., Jürgensmeier, Juliane M., Billin, Andrew, Xu, Ren, Patterson, Scott, Pagratis, Nikos
Format: Artigo
Sprog:Inglês
Udgivet: SAGE Publications 2018
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6151956/
https://ncbi.nlm.nih.gov/pubmed/30011241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2472555218786165
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker